2010
DOI: 10.1038/tpj.2010.74
|View full text |Cite
|
Sign up to set email alerts
|

Gene–gene interactions of the INSIG1 and INSIG2 in metabolic syndrome in schizophrenic patients treated with atypical antipsychotics

Abstract: The use of atypical antipsychotics (AAPs) is associated with increasing the risk of the metabolic syndrome (MetS), which is an important risk factor for cardiovascular disease and diabetes. Two insulin-induced gene (INSIG) isoforms, designated INSIG-1 and INSIG-2 encode two proteins that mediate feedback control of lipid metabolism. In this genetic case-control study, we investigated whether the common variants in INSIG1 and INSIG2 genes were associated with MetS in schizophrenic patients treated with atypical… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
29
1

Year Published

2012
2012
2018
2018

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 50 publications
(31 citation statements)
references
References 27 publications
1
29
1
Order By: Relevance
“…In this study, the overall prevalence of MetS in the 621 patients with clozapine treatment was 41.8% (260/621), which is higher than that (22%) reported by another study in a Han Chinese sample (Liou et al, 2012). The possible reasons for this could be due to longer duration of drug usage, and the clozapine received in our study, which induces high potency for MetS.…”
Section: Discussioncontrasting
confidence: 73%
“…In this study, the overall prevalence of MetS in the 621 patients with clozapine treatment was 41.8% (260/621), which is higher than that (22%) reported by another study in a Han Chinese sample (Liou et al, 2012). The possible reasons for this could be due to longer duration of drug usage, and the clozapine received in our study, which induces high potency for MetS.…”
Section: Discussioncontrasting
confidence: 73%
“…The quality of the isolated genomic DNA was evaluated using agarose gel electrophoresis, and the quantity was determined by spectrophotometry [16,17]. SNP genotyping was carried out using the custom Taiwan BioBank chips and run on the Axiom Genome-Wide Array Plate System (Affymetrix, Santa Clara, CA, USA).…”
Section: Methodsmentioning
confidence: 99%
“…The main weakness of this study is an insufficient sample size of obese cases in the context of polygenic studies (Li and Meyre, 2013;Lin et al, 2009;Liou et al, 2012;Lane et al, 2012). In future work, prospective clinical trials with very large sample sizes are necessary to facilitate a thorough evaluation of the association of this SNP with T2D, obesity, and T2D/obesity-related metabolic traits Liou et al, 2012;Lane et al, 2012).…”
Section: Tablementioning
confidence: 99%